MSDS

MSDS

View MSDS Section :

SECTION 1 - PRODUCT AND COMPANY IDENTIFICATION

Product Name:	Glisten PC Two-Component Clearcoat
Product Use/Restriction:	Clear coat
Manufacturer Name:	POR-15, Inc.
Address:	P.O. Box 1235 Morristown, NJ 07962-1235
General Phone Number:	800-457-6715
Customer Service Phone Number:	973-887-1999
Technical Product Information:	800-457-6715
Emergency Phone Number:	1-800-457-6715
CHEMTREC:	For emergencies in the US, call CHEMTREC: 800-424-9300
MSDS Format:	According to ANSI Z400.1-2004

SECTION 2 - COMPOSITION/INFORMATION ON INGREDIENTS

Chemical Name	CAS#	Ingredient Percent

Ethyl Benzene	100-41-4	10 - 30 by weight
Acrylic polymer	Proprietary	10 - 30 by weight
Xylene (Mixture of isomers)	1330-20-7	30 - 60 by weight

SECTION 3 - HAZARDS IDENTIFICATION

Route of Exposure:
Potential Health Effects:	Eyes: severe irritation; tearing skin, discoloration: drying; breathing: irritation, dizziness, unconsciousness (for solvent). For isocyanates: coughing, irritation of mucous membranes and respiratory tract. SKIN EFFECTS: Slight to moderate irritation; skin sensitizer in guinea pigs. No conclusive evidence has been developed to indicate that Glisten PC is carcinogenic, teratogenic or that it causes reproductive effects in animals or humans. Active resin in Glisten PC has been reported by NIOSH to be mutagenic to Salmonella Typhimurium bacteria in the presence of a mammalian liver activation system. There is not full agreement in the scientific community on the significance of these Ames test results and their relationship to human safety in assessing the risk of cancer in man.
Eye:	HUMAN EFFECTS OF OVEREXPOSURE: Liquid, vapors, or aerosols are irritating to the eyes and can cause lachrymation (tearing effect). Corneal damage can occur; however, indications are that the damage is reversible and does not result in permanent injury.
Skin:	HUMAN EFFECTS OF OVEREXPOSURE: Glisten PC reacts with skin protein and tissue moisture and can cause localized irritation as well as discoloration. Prolonged contact could produce reddening, swelling, or blistering and, in some individuals, skin sensitization resulting in dermatitis.
Inhalation:	HUMAN EFFECTS OF OVEREXPOSURE: Inhalation of Glisten PC vapors in concentrations above 0.02 ppm can produce irritation of the mucous membranes in the respiratory tract, running nose, sore throat, productive cough and a reduction of lung function. Extensive exposures to concentrations well above the TLV could lead to bronchitis, bronchial spasm and pulmonary edema. These effects are usually reversible. However, due to low volatility, high exposures are not anticipated except if the material is overheated or sprayed as an aerosol into the air. Hypersensitivity pneumonitis has also been reported. Another type of response is hyperreactivity or hypersensitization. Persons with a preexisting unspecific bronchial hyperreactivity or persons with a specific isocyanate hypersensitivity (as a result of previous repeated overexposure or a single large dosage)will respond to small isocyanate concentrations at levels well below the TLV of 0.02 ppm. Symptoms could be immediate or delayed and include chest tightness, respiratory distress or asthmatic attack.
Ingestion:	HUMAN EFFECTS OF OVEREXPOSURE: Ingestion could result in irritation and some corrosive action in the mouth, stomach tissue and digestive tract. However, it is not considered a common occupational route of exposure.
Chronic Health Effects:
Signs/Symptoms:
Target Organs:
Aggravation of Pre-Existing Conditions:

SECTION 4 - FIRST AID MEASURES

Eye Contact:	Immediately flush eyes with plenty of water for 15 to 20 minutes occasionally lifting eyelids. Get medical attention, if irritation or symptoms of overexposure persists.
Skin Contact:	Immediately wash skin with plenty of soap and water for 15 to 20 minutes, while removing contaminated clothing and shoes. Get medical attention if irritation develops or persists. Wash contaminated clothing thoroughly before re-use.
Inhalation:	If inhaled, remove to fresh air. If not breathing, give artificial respiration or give oxygen by trained personnel. Seek immediate medical attention if necessary. Asthmatic-type symptoms may develop and may be immediate or delayed up to several hours. Treatment is essentially symptomatic.
Ingestion:	If swallowed, do NOT induce vomiting. Call a physician or poison control center immediately. Never give anything by mouth to an unconscious person.Give 250 ml of milk or water to drink. Consult physician.
Note to Physicians:
Other First Aid:

SECTION 5 - FIRE FIGHTING MEASURES

Flammable Properties:	Combustible liquid. At elevated temperatures, vapors can form an ignitable mixture with air. Vapors can flow along surfaces to distant ignition sources and flash back.
Flash Point:	40°C (104°F)
Flash Point Method:	TCC
Auto Ignition Temperature:	246°C (475°F)
Lower Flammable/Explosive Limit:	1%
Upper Flammable/Explosive Limit:	7%
Fire Fighting Instructions:	Avoid spreading burning liquid with water for cooling purposes.
Extinguishing Media:	Dry chemical (e.g. monoammonium phosphate, potassium sulfate, and potassium chloride), carbon dioxide, high expansion (proteinic) chemical foam, sand.
Unsuitable Media:
Protective Equipment:	As in any fire wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full protective gear.
Unusual Fire Hazards:	Keep work areas free of hot metal surfaces and other sources of ignition.
Hazardous Combustion Byproducts:

SECTION 6 - ACCIDENTAL RELEASE MEASURES

Personnel Precautions:
Environmental Precautions:
Spill Cleanup Measures:	Eliminate source of ignition of vapors, wear protective clothing while cleaning up; absorb on sand, clay, or absorbent material.
Other Precautions:

SECTION 7 - HANDLING and STORAGE

Handling:
Storage:	STORAGE TEMPERATURE (min/max): 32 deg F (0 deg C)/122 deg F (50 deg C) AVERAGE SHELF LIFE: 12 months @ 77 deg F (25 deg C) Store in tightly closed container. At maximum storage temperatures noted, material may slowly polymerize without hazard. Ideal storage temperature range is 50-81 deg F (10-27 deg C).
Work Practices:
Special Handling Procedures:
Hygiene Practices:

SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION - EXPOSURE GUIDELINES

Engineering Controls:	Use appropriate engineering control such as process enclosures, local exhaust ventilation, or other engineering controls to control airborne levels below recommended exposure limits.Ventilation as required to maintain air concentrations below TLV's. If material is spray-applied, ventilation should be provided and air supplied respirators worn. Exhaust air may need to be cleaned by scrubbers or filters to reduce environmental contamination.
Eye/Face Protection:	Wear appropriate protective glasses or splash goggles as described by 29 CFR 1910.133, OSHA eye and face protection regulation, or the European standard EN 166. Contact lenses should not be worn.
Skin Protection Description:	Cover as much of the exposed skin area as possible with appropriate clothing. If skin creams are used, keep the area covered to a minimum. & dbo_Section8.HandProtectionDescription
Respiratory Protection:	A NIOSH approved air-purifying respirator with an organic vapor cartridge or canister approved for use in isocyanate containing environments may be permissible under certain circumstances where airborne concentrations are expected to exceed exposure limits. In spray applications you must protect against exposure to both vapor and spray mist. An air-supplied respirator is strongly recommended for spray application. Protection provided by air purifying respirators is limited. Use a positive pressure air supplied respirator if there is any potential for an uncontrolled release, exposure levels are not known, or any other circumstances where air purifying respirators may not provide adequate protection.
Other Protective:	Eyewash and deluge shower should be available.

EXPOSURE GUIDELINES

Ethyl Benzene :
Guideline ACGIH:	100 ppm TLV-STEL: 125 ppm TLV-TWA: 100 ppm
Guideline OSHA:	100 ppm PEL-TWA: 100 ppm
Xylene (Mixture of isomers) :
Guideline ACGIH:	TLV-TWA: 100 ppm TLV-STEL: 150 ppm
Guideline OSHA:	OSHA-TWA: 100 ppm

Notes :

SECTION 9 - PHYSICAL and CHEMICAL PROPERTIES

Flash Point:	40°C (104°F)
Flash Point Method:	TCC
Auto Ignition Temperature:	246°C (475°F)
VOC Content:	595 gm/liter

SECTION 10 - STABILITY and REACTIVITY

Chemical Stability:	Stable under normal conditions.
Reactivity:
Hazardous Polymerization:	Will not occur under normal conditions.
Conditions to Avoid:	Temperatures below 0°C (32°F) or above 50°C (122°F). To maintain freshness: Avoid contact with water, alcohols, amines, strong bases, metal compounds or surface active materials.
Incompatible Materials:
Special Decomposition Products:

SECTION 11 - TOXICOLOGICAL INFORMATION

Ethyl Benzene :
Eye:	Eye - Rabbit Standard Draize Test.: 500 mg
Skin:	Intraperitoneal. - Mouse LD50: 2624 uL/kg [Details of toxic effects not reported other than lethal dose value.] Administration onto the skin - Rabbit LD50: 17800 uL/kg [Details of toxic effects not reported other than lethal dose value.] Oral - Rat LD50: 3500 mg/kg [Details of toxic effects not reported other than lethal dose value.] Administration onto the skin - Rabbit LD50: >5000 mg/kg [Details of toxic effects not reported other than lethal dose value.] Oral - Rat LD50: 3500 mg/kg [Liver - Other changes Kidney/Ureter/Bladder - Other changes] Administration onto the skin - Rabbit Open irritation test: 15 mg/24H
Inhalation:	Inhalation - Rat LC50: 55000 mg/m3/2H [Details of toxic effects not reported other than lethal dose value.] Inhalation - Mouse LC50: 35500 mg/m3/2H [Details of toxic effects not reported other than lethal dose value.]
Ingestion:	Oral - Rat LD50: 3500 mg/kg [Details of toxic effects not reported other than lethal dose value.] Oral - Rat LD50: 3500 mg/kg [Liver - Other changes Kidney/Ureter/Bladder - Other changes]
Carcinogenicity:	IARC: Group 2B: Possibly carcinogenic to humans.
Xylene (Mixture of isomers) :
Eye:	Eye - Rabbit Standard Draize Test.: 87 mg Eye - Rabbit Standard Draize Test.: 5 mg/24H Eye - Human Standard Draize Test.: 200 ppm
Skin:	Oral - Rat LD50: 4300 mg/kg [Liver - Other changes Kidney/Ureter/Bladder - Other changes] Intraperitoneal. - Rat LD50: 2459 mg/kg [Details of toxic effects not reported other than lethal dose value.] Subcutaneous - Rat LD50: 1700 mg/kg [Details of toxic effects not reported other than lethal dose value.] Oral - Mouse LD50: 2119 mg/kg [Details of toxic effects not reported other than lethal dose value.] Intraperitoneal. - Mouse LD50: 1548 mg/kg [Details of toxic effects not reported other than lethal dose value.] Administration onto the skin - Rabbit LD50: >1700 mg/kg [Details of toxic effects not reported other than lethal dose value.]
Inhalation:	Inhalation - Rat LC50: 5000 ppm/4H [Details of toxic effects not reported other than lethal dose value.]
Ingestion:	Oral - Rat LD50: 4300 mg/kg [Liver - Other changes Kidney/Ureter/Bladder - Other changes] Oral - Mouse LD50: 2119 mg/kg [Details of toxic effects not reported other than lethal dose value.]
Carcinogenicity:	IARC: Group 3: Unclassifiable as to carcinogenicity to humans.

SECTION 12 - ECOLOGICAL INFORMATION

SECTION 13 - DISPOSAL CONSIDERATIONS

SECTION 14 - TRANSPORT INFORMATION

DOT Shipping Name:	Paint
DOT UN Number:	UN1263
DOT Hazard Class:	3
DOT Packing Group:	III

SECTION 15 - REGULATORY INFORMATION

Ethyl Benzene :
TSCA Inventory Status:	Listed
California PROP 65:	Listed: cancer
New Jersey:	Listed: NJ Hazardous List; Substance Number: 0851
Massachussetts:	Listed: Massachusetts Oil and Hazardous List
Pennsylvania:	Listed
Canada DSL:	Listed
Xylene (Mixture of isomers) :
TSCA Inventory Status:	Listed
State Regulations:	Listed in the New Jersey State Right to Know List. Listed in the Pennsylvania State Hazardous Substances List.
Canada DSL:	Listed

SECTION 16 - ADDITIONAL INFORMATION